BDXBECTON DICKINSON & CO
Surgical & Medical Instruments & Apparatus
- Revenue
- $21.8B
- 8.2% YoY
- Operating margin
- 11.8%
- 0.6% YoY
- EBITDA
- $5.0B
- 7.6% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 2.5×
- $12.8B net debt
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear204% of net incomeCash flow under 80% of net income
- Dilutive SBCClear1% of revenueOver 10% of revenue
- Payouts exceed cash flowClear64% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyFired51% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $19.1B | $18.9B | $19.4B | $20.2B | $21.8B | 8.2% |
| Operating income | $2.3B | $2.3B | $2.1B | $2.4B | $2.6B | 7.6% |
| Net income | $2.1B | $1.8B | $1.5B | $1.7B | $1.7B | 1.6% |
| Operating cash flow | $4.6B | $2.5B | $3.0B | $3.8B | $3.4B | 11% |
| Capex | $1.2B | $973M | $874M | $725M | $760M | 4.8% |
| Stock-based comp | $229M | $233M | $259M | $247M | $258M | 4.5% |
| Buybacks | $1.8B | $500M | $0 | $500M | $1.0B | 100% |
| Dividends | $1.0B | $1.1B | $1.1B | $1.1B | $1.2B | 8.7% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $29K · 2
- Net
- −$29K
Pay vs performance
No pay-versus-performance disclosure yet.